Check out the companies making headlines before the bell. Abercrombie & Fitch — Shares slipped nearly 4% despite the apparel retailer’s earnings beat and strong holiday guidance . Abercrombie & Fitch reported third-quarter earnings of $2.50 per share, topping the $2.39 per share LSEG consensus estimate. Revenue was $1.21 billion, versus the $1.19 billion expected. The company also raised its full-year guidance. Best Buy — Shares slid 7.4% after Best Buy posted third-quarter results that missed analyst expectations and cut its full-year sales forecast. Adjusted earnings of $1.26 per share came in below the $1.29 per-share earnings expected by analysts polled by LSEG. Revenue of $9.45 billion missed the $9.63 billion consensus estimate. Kohl’s — Shares plummeted nearly 17% following the retailer’s weaker-than-expected third-quarter earnings. Kohl’s earned 20 cents per share on revenue of $3.51 billion for the period, while analysts surveyed by LSEG had penciled in 28 cents per share on $3.64 billion in revenue. Stellantis — Shares of European and Japanese automakers slid after President-elect Donald Trump said in a Truth Social post on Monday that he plans to raise tariffs on products from China, Mexico and Canada. Many carmakers have factories in Mexico. Stellantis, which is considering revising its plan to expand manufacturing into Mexico, saw shares dip more than 3.5% on the news. Automakers General Motors and Ford Motor also edged more than 4% and 2%, respectively. Dick’s Sporting Goods — Shares of the sporting goods retailer jumped 6.6% after the company’ s quarterly results beat expectations and indicated a strong holiday shopping season outlook. Dick’s raised its full-year guidance and said it now expects fiscal 2024 same-store sales to grow between 3.6% and 4.2%, up from a previous range of 2.5% to 3.5%. Zoom Video Communications — Shares slipped roughly 10.5% after the video software maker gave fiscal fourth-quarter adjusted earnings per share guidance that was roughly in line with estimates. Zoom exceeded Wall Street’s profit and revenue estimates for its fiscal third quarter, however. Amgen — Shares fell more than 3% after the company said its experimental weight loss drug helped patients lose up to 20% of their weight after a year. However, those trial results appeared to be on the low end of investor expectations. Rivian Automotive — Shares of the electric vehicle maker rose about 9% after the company said on received conditional approval for a government loan of up to $6.6 billion to support its production capacity, including the construction of its Georgia EV plant. Fluence Energy — The energy storage stock fell about 4% after the company’s fourth-quarter revenue missed expectations. Fluence reported $1.23 billion in revenue for the quarter, below the $1.28 billion expected by analysts, according to FactSet. Earnings per share of 34 cents was ahead of the 28 cents expected by analysts. Novo Nordisk , Eli Lilly — Shares of drugmakers Novo Nordisk and Eli Lilly rose more than 2.5% and 4.7%, respectively, after the Biden administration proposed a new rule that Medicare and Medicaid would cover costly weight-loss drugs for Americans with obesity . Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound weekly injectables treat obesity. — CNBC’s Sarah Min, Sean Conlon, Fred Imbert, Jesse Pound, Michelle Fox Theobald contributed reporting.
Jamie Dimon, CEO of JPMorgan Chase, leaves the U.S. Capitol after a meeting with Republican members of the Senate Banking, Housing and Urban Affairs Committee on the issue of de-banking on Feb. 13, 2025.
Dimon, the veteran CEO and chairman of the biggest U.S. bank by assets, explained his worldview during his bank’s annual investor day meeting in New York. He said he believes the risks of higher inflation and even stagflation aren’t properly represented by stock market values, which have staged a comeback from lows in April.
“We have huge deficits; we have what I consider almost complacent central banks,” Dimon said. “You all think they can manage all this. I don’t think” they can, he said.
“My own view is people feel pretty good because you haven’t seen effective tariffs” yet, Dimon said. “The market came down 10%, [it’s] back up 10%; that’s an extraordinary amount of complacency.”
Dimon’s comments follow Moody’s rating agency downgrading the U.S. credit rating on Friday over concerns about the government’s growing debt burden. Markets have been whipsawed the past few months over worries that President Donald Trump‘s trade policies will raise inflation and slow the world’s largest economy.
Dimon said Monday that he believed Wall Street earnings estimates for S&P 500 companies, which have already declined in the first weeks of Trump’s trade policies, will fall further as companies pull or lower guidance amid the uncertainty.
In six months, those projections will fall to 0% earnings growth after starting the year at around 12%, Dimon said. If that were to happen, stocks prices will likely fall.
“I think earnings estimates will come down, which means PE will come down,” Dimon said, referring to the “price to earnings” ratio tracked closely by stock market analysts.
The odds of stagflation, “which is basically a recession with inflation,” are roughly double what the market thinks, Dimon added.
Separately, one of Dimon’s top deputies said that corporate clients are still in “wait-and-see” mode when it comes to acquisitions and other deals.
Investment banking revenue is headed for a “mid-teens” percentage decline in the second quarter compared with the year-earlier period, while trading revenue was trending higher by a “mid-to-high” single digit percentage, said Troy Rohrbaugh, a co-head of the firm’s commercial and investment bank.
On the ever-present question of Dimon’s timeline to hand over the CEO reins to one of his deputies, Dimon said that nothing changed from his guidance last year, when he said he would likely remain for less than five more years.
“If I’m here for four more years, and maybe two more” as executive chairman, Dimon said, “that’s a long time.”
Of all the executive presentations given Monday, consumer banking chief Marianne Lake had the longest speaking time at a full hour. She is considered a top successor candidate, especially after Chief Operating Officer Jennifer Piepszak said she would not be seeking the top job.
Check out the companies making headlines in midday trading. UnitedHealth — The health insurer’s stock popped roughly 7% as investors scooped up shares of the beaten-down name, which lost 23% last week. UnitedHealth had suspended its 2025 guidance, announced that its CEO is stepping down and is reportedly the subject of a U.S. Department of Justice investigation . Reddit — Shares of the social media stock dropped more than 4% following a downgrade to equal weight from overweight at Wells Fargo. The firm said search traffic disruptions at Reddit are likely to become lasting as Google’s search integrates full artificial intelligence capabilities. Tesla , Palantir — Shares of retail investor favorites Tesla and Palantir each slid more than 3% as key tech stocks led Monday’s stock market losses. Regeneron Pharmaceuticals — Shares of the drugmaker dropped about 1% after the company announced it had agreed to pay $256 million to buy most of the assets of genetic data company 23andMe out of bankruptcy. Regeneron’s deal does not include Lemonaid Health, 23andMe’s telehealth subsidiary. Bath & Body Works — Shares ticked 1% lower after the personal care retailer said CEO Gina Boswell would step down immediately. The company said former Nike executive Daniel Heaf would replace her. Alibaba — U.S.-listed shares of the Chinese e-commerce giant traded 1% lower after the New York Times reported that the Trump administration has raised concerns about Apple’ s plan to use Alibaba’s A.I. on iPhones in China. TXNM Energy — Shares of the energy company popped 7% after TXNM agreed to be acquired by Blackstone’s infrastructure unit. TXNM Energy shareholders will receive $61.25 in cash for each share as part of the deal. — CNBC’s Alex Harring, Jesse Pound and Michelle Fox contributed reporting.
Sebastian Siemiatkowski, CEO of Klarna, speaking at a fintech event in London on Monday, April 4, 2022.
Chris Ratcliffe | Bloomberg via Getty Images
Klarna saw its losses jump in the first quarter as the popular buy now, pay later firm applies the brakes on a hotly anticipated U.S. initial public offering.
The Swedish payments startup said its net loss for the first three months of 2025 totaled $99 million — significantly worse than the $47 million loss it reported a year ago. Klarna said this was due to several one-off costs related to depreciation, share-based payments and restructuring.
Revenues at the firm increased 13% year-over-year to $701 million. Klarna said it now has 100 million active users and 724,00 merchant partners globally.
It comes as Klarna remains in pause mode regarding a highly anticipated U.S. IPO that was at one stage set to value the SoftBank-backed company at over $15 billion.
Klarna put its IPO plans on hold last month due to market turbulence caused by President Donald Trump’s sweeping tariff plans. Online ticketing platform StubHub also put its IPO plans on ice.
Prior to the IPO delay, Klarna had been on a marketing blitz touting itself as an artificial intelligence-powered fintech. The company partnered up with ChatGPT maker OpenAI in 2023. A year later, Klarna used OpenAI technology to create an AI customer service assistant.
Last week, Klarna CEO Sebastian Siemiatkowski said the company was able to shrink its headcount by about 40%, in part due to investments in AI.